Product Information

DULOXETINE HCL DR 30 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $0.0994 per EA under NDC 00228289103. Its NADAC has been published 665 times since Feb 19, 2014.

FDA first approved this application on Dec 17, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DULOXETINE HCL DR 30 MG CAP

Duloxetine
$0.0994per EA

Strength

30 mg/1

NDC

00228289103

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE PELLETS

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DULOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090776

FDA Approved

12/17/2013

TE Code

AB

On Market Since

12/17/2013

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 665 times since Feb 19, 2014, and over the history we have for it it has declined 98.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0994 per EA
All-time high$6.0216 (Mar 12, 2014)
All-time low$0.0696 (May 22, 2024)
52-week high$0.1058
52-week low$0.0781
Median price$0.1485
Average price$0.4731
Largest weekly change-55.4% (Sep 17, 2014)
Weeks tracked665
Tracking sinceFeb 19, 2014

Price History

1W

0.0%

1M

-2.9%

3M

-2.0%

6M

+4.5%

1Y

+26.8%

3Y

+0.6%

5Y

-17.0%

All

-98.3%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by Actavis Pharma, Inc., is $0.0994 per EA (NDC 00228289103), effective Nov 11, 2026.

How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?

Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has declined 98.3%. It has been tracked across 665 weekly CMS publications since Feb 19, 2014.

What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?

Since Feb 19, 2014, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0696 (May 22, 2024) to a high of $6.0216 (Mar 12, 2014), with a median of $0.1485 per EA.

Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 30 MG CAP, is $0.0782 per EA — about 21% below DULOXETINE HCL DR 30 MG CAP.

Who manufactures DULOXETINE HCL DR 30 MG CAP?

DULOXETINE HCL DR 30 MG CAP (NDC 00228289103) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.